Remarkable advances in EDC systems you need to know with Zach Taft
Zach Taft, Co-Founder of the Clinical Research Innovation Consortium at Memorial Sloan Kettering Cancer Center, shared on LinkedIn:
“‘We anticipate more growth and innovation in clinical trials and drug development over the next five years than in the past five decades.
This rapid progress is driven by the synergy between these stakeholders and technological advancements.
The ultimate beneficiaries of these efforts will be the patients having greater access, global, to life-saving treatments for devastating diseases like cancer.
By leveraging the combined strengths and expertise of sponsors, sites, tech companies, and regulatory bodies, we’re creating a more efficient and effective clinical trial ecosystem that holds tremendous promise for the future of healthcare around the world.’
It has been exciting to see the pace and advancement of clinical trial technologies, as well as the willingness of these stakeholders to come together to champion these innovations.
This is a unique opportunity where everyone in the ecosystem benefits from these advancements, especially patients and their families!
Thank you Moe Alsumidaie and The Clinical Trial Vanguard team for highlighting the valuable efforts the IgniteData team and our partners are working on in this space.”
Additional information.
Source: Zach Taft/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023